|
DDX47 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.698300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.306200E-02 |
| Normal-vs-Stage2 |
8.201400E-01 |
| Normal-vs-Stage3 |
1.635240E-01 |
| Normal-vs-Stage4 |
2.121200E-01 |
| Stage1-vs-Stage2 |
2.191400E-01 |
| Stage1-vs-Stage3 |
6.636400E-01 |
| Stage1-vs-Stage4 |
7.175600E-01 |
| Stage2-vs-Stage3 |
4.096800E-01 |
| Stage2-vs-Stage4 |
4.534600E-01 |
| Stage3-vs-Stage4 |
9.815000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.379800E-02 |
| Normal-vs-AfricanAmerican |
2.629500E-02 |
| Normal-vs-Asian |
3.450300E-02 |
| Caucasian-vs-AfricanAmerican |
4.429400E-01 |
| Caucasian-vs-Asian |
3.713600E-01 |
| AfricanAmerican-vs-Asian |
9.400800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.387600E-01 |
| Normal-vs-Female |
3.499800E-02 |
| Male-vs-Female |
4.396000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.057600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.123990E-01 |
| Normal-vs-Age(61-80Yrs) |
5.762000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.518800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.420000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.473900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.478600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.642200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.314800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.999400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.372600E-01 |
| Classical-VS-Follicular |
2.26879999999374E-05 |
| Classical-VS-Other |
2.463200E-01 |
| Classical-VS-Normal |
1.544870E-03 |
| Tall-VS-Follicular |
3.042500E-03 |
| Tall-VS-Other |
1.837600E-01 |
| Tall-VS-Normal |
9.878500E-03 |
| Follicular-VS-Other |
6.493800E-01 |
| Follicular-VS-Normal |
1.521220E-01 |
| Other-VS-Normal |
9.148800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.439400E-01 |
| Normal-vs-N1 |
6.673400E-01 |
| N0-vs-N1 |
9.296600E-01 |
|
|
